Related Experiment Video
Updated: Jun 7, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
A community health concern: respiratory syncytial virus and children
1Rush-Copley Medical Center, Aurora, IL, USA. susan6664@aol.com
Insights
Respiratory syncytial virus (RSV) affects nearly all children, causing mild symptoms in older individuals but severe illness in infants. Palivizumab is recommended by the American Academy of Pediatrics for high-risk infants to prevent RSV infections.
Area of Science:
- Pediatrics
- Virology
- Public Health
Background:
- Respiratory syncytial virus (RSV) is a common viral pathogen.
- RSV infection typically causes mild, cold-like symptoms in adults and older children.
- In infants and young children, RSV can lead to severe lower respiratory tract infections, posing a significant health burden.
Purpose of the Study:
- To summarize the impact of RSV on young children.
- To highlight the importance of prevention strategies for high-risk infants.
- To reference the American Academy of Pediatrics' guidelines on RSV prevention.
Main Methods:
- Review of existing literature on RSV epidemiology and clinical presentation.
- Analysis of public health recommendations for RSV prevention.
- Examination of the role of Palivizumab in pediatric RSV management.
Main Results:
- Nearly all children are infected with RSV by age three.
- RSV is a leading cause of serious respiratory illness in infants.
- Preventive measures, including Palivizumab, are crucial for high-risk populations.
Conclusions:
- RSV poses a substantial risk to infant health, necessitating targeted preventive strategies.
- Palivizumab is a key component of RSV prevention guidelines for high-risk infants.
- Effective prevention of RSV reduces disease incidence and family burden.
Abstract:
Respiratory syncytial virus (RSV) is a significant health issue. Nearly all children contract RSV by 3 years of age. This virus causes mild cold-like symptoms in older children and adults. However, in infants and toddlers, it causes serious lower respiratory tract infections. Recovery from RSV can be lengthy, and caring for an unwell child can become a burden for a family. Prevention plans for those children that are at highest risk have been helpful in reducing the incidence of RSV. The American Academy of Pediatrics outlines the use of Palivizumab as part of its RSV prevention guidelines.
Related Concept Videos
Respiratory Syncytial Virus Disease
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pulmonary Cycle: Exhalation
Microbiota of the Respiratory Tract
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

